A method for splitting propranolol using menthol-lactic acid hydrophobic deep eutectic solvent

A technology of deep eutectic solvent and propranolol hydrochloride, which is applied in the field of drug preparation, can solve problems such as general splitting effect, and achieve the effects of reducing harm to users and the environment, low cost, and low difficulty

Active Publication Date: 2021-09-21
SOUTH CHINA UNIV OF TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most extraction systems have mediocre resolution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for splitting propranolol using menthol-lactic acid hydrophobic deep eutectic solvent
  • A method for splitting propranolol using menthol-lactic acid hydrophobic deep eutectic solvent
  • A method for splitting propranolol using menthol-lactic acid hydrophobic deep eutectic solvent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] A method for splitting propranolol using a menthol-lactic acid hydrophobic deep eutectic solvent, comprising the following steps:

[0050] (1) Put (-)-menthol and L(+)-lactic acid in a round-bottomed flask with a ratio of 1:1 and mix them evenly, and carry out the first heat treatment at a stirring state with a rotation speed of 800rpm, The temperature of the first heat treatment is 80°C, and the time of the first heat treatment is 1h, and a clear and transparent solution is obtained, then the stirring is stopped, and the heat preservation treatment is carried out at 80°C for 0.5h, and cooled to room temperature to obtain a hydrophobic low ethanol Solvent (-)-menthol-L(+)-lactic acid;

[0051] (2) 500mg of propranolol hydrochloride is added in 5mL alkaline solution (the NaOH solution that selects concentration to be 1.5mol / L here), in the stirring state that rotating speed is 800rpm, carry out heat treatment for the second time, heat for the second time The temperature...

Embodiment 2

[0061] A method for splitting propranolol using a menthol-lactic acid hydrophobic deep eutectic solvent, comprising the following steps:

[0062] (1) Put (-)-menthol and L(+)-lactic acid with the amount of 1:1 in a round-bottomed flask and mix evenly, and carry out the first heat treatment under the stirring state with a rotation speed of 600rpm. The temperature of the second heat treatment is 80°C, and the time of the first heat treatment is 1.5h to obtain a clear and transparent solution, then stop stirring, carry out heat preservation treatment at 80°C for 2h, and cool to room temperature to obtain a hydrophobic deep eutectic solvent (-)-menthol-L(+)-lactic acid;

[0063] (2) 500mg of propranolol hydrochloride is added in 5.5mL alkaline solution (selection concentration is the NaOH solution of 1.5mol / L here), in the stirring state that rotating speed is 600rpm, carry out heat treatment for the second time, the second time The heat treatment temperature is 45°C, the second ...

Embodiment 3

[0068] A method for splitting propranolol using a menthol-lactic acid hydrophobic deep eutectic solvent, comprising the following steps:

[0069] (1) Place (-)-menthol and L(+)-lactic acid in a round-bottomed flask with a ratio of 1:1.3 and mix them uniformly, and carry out the first heat treatment at a stirring state of 500 rpm. The temperature of the first heat treatment is 60°C, and the time of the first heat treatment is 1.5h to obtain a clear and transparent solution, then stop stirring, carry out heat preservation treatment at 60°C for 0.5h, and cool to room temperature to obtain a low hydrophobicity solution. Eutectic solvent (-)-menthol-L(+)-lactic acid;

[0070] (2) 500mg propranolol hydrochloride is added in 5mL alkaline solution (concentration is the KOH solution of 2mol / L for selection here), in the stirring state that rotating speed is 500rpm, carry out heat treatment for the second time, heat treatment for the second time The temperature is 35°C, the time of the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for splitting propranolol by using menthol-lactic acid hydrophobic deep eutectic solvent. The method comprises: uniformly mixing (‑)‑menthol and L(+)‑lactic acid, heating under stirring, then stopping stirring for heat preservation treatment to obtain a hydrophobic deep eutectic solvent; adding propranolol hydrochloride to lye , heated under stirring, extracted, dried, filtered, and evaporated to remove the solvent to obtain free propranolol, and recrystallized to obtain free propranolol; water, free propranolol and hydrophobic Mix the molten solvent evenly to obtain a mixed solution, and adjust the pH value to 5.0-9.0; stir and stand still to separate the phases of the system to obtain an upper phase and a lower phase; remove the lower phase and remove the solvent to obtain R-(+)-propranolol Er, complete the splitting of propranolol. The method provided by the invention adopts a hydrophobic deep eutectic solvent, and has the characteristics of environmental protection, simplicity, convenience and high separation degree.

Description

technical field [0001] The invention relates to the technical field of medicine preparation, in particular to a method for splitting propranolol by using a menthol-lactic acid hydrophobic deep eutectic solvent. Background technique [0002] Chiral compounds are widely used in the fields of pharmaceuticals, fine chemicals, and materials science because of their unique physiological activities. However, it is very difficult to obtain a single enantiomer, which has attracted the attention of researchers at home and abroad. Chiral drugs belong to one class of chiral compounds. Generally speaking, among the two enantiomers of chiral drugs, one has better efficacy, while the other may be ineffective or even toxic. Propranolol, also known as propranolol and propranolol, is a non-selective beta-receptor blocker. Clinically, it is mainly used to treat arrhythmia caused by various reasons, and it can also be used for angina pectoris and hypertensive pheochromocytoma (preparation bef...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07C213/10C07C217/30C07B57/00
CPCC07B57/00C07B2200/07C07C213/10C07C217/30
Inventor 陈砺杨婵媛樊涛涛邱舜国严宗诚
Owner SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap